3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
1
Leukemia
1
Interventions
tisagenlecleucel
1
tipifarnib
1
loncastuximab tesirine
1
glucarpidase
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Mycophenolic Acid
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Carboxypeptidases
1
Busulfan
1
Brentuximab Vedotin
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Lymphoma
×
tisagenlecleucel
×
Clear all
NCT03601442
2026-04-23
Managed Access Programs for CTL019, Tisagenlecleucel
Novartis
Available